凝溶膠蛋白(GSN)檢測試劑盒(化學發(fā)光免疫分析法)
CLIA Kit for Gelsolin (GSN)
GS; AGEL; ADF; Brevin; Gelsolin Amyloidosis,Finnish Type; Actin-depolymerizing factor
- 編號SCA372Hu
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 實驗方法雙抗夾心
- 反應時長2h, 40min
- 檢測范圍13.7-10,000pg/mL
- 靈敏度最小可檢測劑量小于等于6.1pg/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價格 ¥ 3528 ¥ 5040 ¥ 22680 ¥ 42840 ¥ 352800
- 欲了解實際交易價格和更多情況,請與當?shù)亟涗N商聯(lián)系!
特異性
本試劑盒用于檢測凝溶膠蛋白(GSN),經檢測與其它相似物質無明顯交叉反應。
由于受到技術及樣本來源的限制,不可能完成對所有相關或相似物質交叉反應檢測,因此本試劑盒有可能與未經檢測的其它物質有交叉反應。
回收率
分別于定值血清及血漿樣本中加入一定量的凝溶膠蛋白(GSN)(加標樣品),重復測定并計算其均值,回收率為測定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 82-96 | 85 |
EDTA plasma(n=5) | 84-92 | 89 |
heparin plasma(n=5) | 84-102 | 93 |
精密度
精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內差:取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定,每個樣本使用同一試劑盒重復測定8次,分別計算不同濃度樣本的平均值及SD值。
批內差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內加入適量的凝溶膠蛋白(GSN),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中凝溶膠蛋白(GSN)含量的測定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 90-104% | 78-89% | 78-99% | 80-91% |
EDTA plasma(n=5) | 84-99% | 98-105% | 98-105% | 97-104% |
heparin plasma(n=5) | 98-105% | 84-98% | 84-103% | 82-98% |
穩(wěn)定性
經測定,試劑盒在有效期內按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。
實驗流程
1. 實驗前標準品、試劑及樣本的準備;
2. 加樣(標準品及樣本)100µL,37°C孵育1小時;
3. 吸棄,加檢測溶液A100μL,37°C孵育1小時;
4. 洗板3次;
5. 加檢測溶液B100µL,37°C孵育30分鐘;
6. 洗板5次;
7. 加底物100µL,37°C孵育10分鐘;
8. 讀數(shù)。
實驗原理
將凝溶膠蛋白(GSN)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標準品或標本,其中的凝溶膠蛋白(GSN)與連接于固相載體上的抗體結合,然后加入生物素化的凝溶膠蛋白(GSN)抗體,將未結合的生物素化抗體洗凈后,加入HRP標記的親和素,再次徹底洗滌后加入底物。加入底物后會產生輝光型光信號。發(fā)射光強度和樣品中的凝溶膠蛋白(GSN)呈正相關。用化學發(fā)光儀測定相對光單位(RLU),計算樣品濃度。
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPA372Hu02 | 凝溶膠蛋白(GSN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA372Hu05 | 凝溶膠蛋白(GSN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA372Hu61 | 凝溶膠蛋白(GSN)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA372Hu06 | 凝溶膠蛋白(GSN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA372Hu03 | 凝溶膠蛋白(GSN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA372Hu04 | 凝溶膠蛋白(GSN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA372Hu01 | 凝溶膠蛋白(GSN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA372Hu61 | 凝溶膠蛋白(GSN)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA372Hu21 | 凝溶膠蛋白(GSN)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAA372Hu05 | 凝溶膠蛋白(GSN)多克隆抗體 | WB; IHC; ICC; IP. |
PAA372Hu04 | 凝溶膠蛋白(GSN)多克隆抗體 | WB; IHC; ICC; IP. |
PAA372Hu06 | 凝溶膠蛋白(GSN)多克隆抗體 | WB; IHC; ICC; IP. |
PAA372Hu03 | 凝溶膠蛋白(GSN)多克隆抗體 | WB; IHC; ICC; IP. |
PAA372Hu02 | 凝溶膠蛋白(GSN)多克隆抗體 | WB; IHC; ICC; IP. |
PAA372Hu01 | 凝溶膠蛋白(GSN)多克隆抗體 | WB; IHC; ICC; IP. |
PAA372Hu08 | 凝溶膠蛋白(GSN)多克隆抗體 | WB; IHC; ICC; IP. |
LAA372Hu71 | 凝溶膠蛋白(GSN)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAA372Hu27 | 凝溶膠蛋白(GSN)單克隆抗體 | WB; IHC; ICC; IP. |
MAA372Hu29 | 凝溶膠蛋白(GSN)單克隆抗體 | WB; IHC; ICC; IP. |
MAA372Hu22 | 凝溶膠蛋白(GSN)單克隆抗體 | WB; IHC; ICC; IP. |
MAA372Hu24 | 凝溶膠蛋白(GSN)單克隆抗體 | WB; IHC |
MAA372Hu21 | 凝溶膠蛋白(GSN)單克隆抗體 | WB; IHC; ICC; IP. |
MAA372Hu23 | 凝溶膠蛋白(GSN)單克隆抗體 | WB; IHC; ICC; IP. |
MAA372Hu25 | 凝溶膠蛋白(GSN)單克隆抗體 | WB; IHC; ICC; IP. |
MAA372Hu26 | 凝溶膠蛋白(GSN)單克隆抗體 | WB; IHC; ICC; IP. |
SEA372Hu | 凝溶膠蛋白(GSN)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
WEA372Hu | 凝溶膠蛋白(GSN)檢測試劑盒(酶聯(lián)免疫吸附試驗法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA372Hu | 凝溶膠蛋白(GSN)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMA372Hu | 凝溶膠蛋白(GSN)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
PSA372Hu01 | 凝溶膠蛋白(GSN)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA372Hu01 | 凝溶膠蛋白(GSN)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Neurochmical Research | Gelsolin in Cerebrospinal Fluid as a Potential Biomarker of Epilepsy [SpringerLink: 3585r8h46q7r0171] |
Journal of Neuroinflammation | Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury [BioMed: 17422094] |
Biomedical Engineering and Informatics | Application of iTRAQ quantitative proteomics in identification of serum biomarkers in breast cancer [IEEE: 6098563] |
European Journal of Obstetrics & Gynecology and Reproductive Biology | Investigation of the actin scavenging system in pre-eclampsia [Pubmed: 24239294] |
The Annals of Thoracic Surgery | Proteomic Study Reveals Plasma Protein Changes in Congenital Heart Diseases [Pubmed: 24565402] |
BMC Anesthesiol.? | The role of plasma gelsolin in cardiopulmonary bypass induced acute lung injury in infants and young children: a pilot study [Pubmed:Pmc4132929] |
Cell Biochemistry and Biophysics | Gelsolin: Role of a Functional Protein in Mitigating Radiation Injury [Pubmed:25164111] |
Neurosci Lett | Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease [PubMed: 25864780] |
Proteomics Clinical Applications | Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients [Pubmed:26680509] |
PROTEOMICS?-?Clinical?Applications | Comparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients. [pubmed:26680509] |
Medicina Intensiva | Serum gelsolin levels in aneurismal subarachnoid hemorrhage: Preliminary results. [pubmed:28365030] |
Journal of?Alzheimers?Disease | Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods [Pubmed:30040720] |
World?Journal of Pediatrics | Plasma gelsolin level predicts acute kidney injury after cardiopulmonary bypass in infants and young children [Pubmed:29427164] |
Biomedicines | Production and Secretion of Gelsolin by Both Human Macrophage-and Fibroblast-like Synoviocytes and GSN Modulation in the Synovial Fluid of Patients with Various?… [Pubmed:35327525] |